Jasper Therapeutics, Inc. (JSPR)
0.6932
-0.02
(-2.28%)
USD |
NASDAQ |
Sep 09, 13:39
Jasper Therapeutics Total Assets (Quarterly) : 11.80M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 11.80M |
| March 31, 2026 | 21.18M |
| December 31, 2025 | 35.78M |
| September 30, 2025 | 57.47M |
| June 30, 2025 | 46.47M |
| March 31, 2025 | 57.60M |
| December 31, 2024 | 79.90M |
| September 30, 2024 | 99.41M |
| June 30, 2024 | 113.93M |
| March 31, 2024 | 125.96M |
| December 31, 2023 | 95.38M |
| September 30, 2023 | 110.40M |
| June 30, 2023 | 124.17M |
| March 31, 2023 | 138.76M |
| Date | Value |
|---|---|
| December 31, 2022 | 48.92M |
| September 30, 2022 | 59.11M |
| June 30, 2022 | 70.37M |
| March 31, 2022 | 80.55M |
| December 31, 2021 | 93.98M |
| September 30, 2021 | 107.21M |
| June 30, 2021 | 100.55M |
| March 31, 2021 | 100.96M |
| December 31, 2020 | 23.76M |
| September 30, 2020 | 101.32M |
| June 30, 2020 | 101.60M |
| March 31, 2020 | 101.79M |
| December 31, 2019 | |
| September 30, 2019 | 0.1028M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Agenus, Inc. | 172.69M |
| Amgen, Inc. | 95.64B |
| Anika Therapeutics, Inc. | 183.47M |
| BioCryst Pharmaceuticals, Inc. | 557.85M |
| Imunon, Inc. | 14.99M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 10.39M |
| Shareholders Equity (Quarterly) | 1.413M |
| Debt to Equity Ratio | 0.1911 |
| Current Ratio | 1.475 |
| Net Debt Paydown Yield | 3.92% |